de Northern Trust Lifecore Biomedical LFCR Historial de posiciones en acciones
Compró
Mantenido
Vendió
| Trimestre | Valor de mercado | Estado | Núm. de acciones |
Cambio en la participación | Valor operado | Peso en el portafolio | Posición de la cartera | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | USD 1.33 M | Comprar |
253,817
+25,659
| +11% | +USD 129 k | ﹤0.01% | 3354 |
|
|
2026
Q1 | USD 849 k | Comprar |
228,158
+3,206
| +1% | +USD 22.1 k | ﹤0.01% | 3412 |
|
|
2025
Q4 | USD 1.84 M | Vender |
224,952
-13,673
| -6% | -USD 101 k | ﹤0.01% | 3048 |
|
|
2025
Q3 | USD 1.76 M | Vender |
238,625
-4,770
| -2% | -USD 36.1 k | ﹤0.01% | 3110 |
|
|
2025
Q2 | USD 1.98 M | Comprar |
243,395
+8,264
| +4% | +USD 55.7 k | ﹤0.01% | 2997 |
|
|
2025
Q1 | USD 1.66 M | Comprar |
235,131
+13,633
| +6% | +USD 84.7 k | ﹤0.01% | 3018 |
|
|
2024
Q4 | USD 1.65 M | Comprar |
221,498
+28,019
| +14% | +USD 179 k | ﹤0.01% | 3133 |
|
|
2024
Q3 | USD 954 k | Comprar |
193,479
+121,630
| +169% | +USD 635 k | ﹤0.01% | 3378 |
|
|
2024
Q2 | USD 369 k | Comprar |
71,849
+10,199
| +17% | +USD 60.4 k | ﹤0.01% | 3616 |
|
|
2024
Q1 | USD 327 k | Vender |
61,650
-18
| -0% | -USD 129 | ﹤0.01% | 3715 |
|
|
2023
Q4 | USD 382 k | Vender |
61,668
-1,508
| -2% | -USD 10.5 k | ﹤0.01% | 3637 |
|
|
2023
Q3 | USD 477 k | Comprar |
63,176
+5,981
| +10% | +USD 54.7 k | ﹤0.01% | 3533 |
|
|
2023
Q2 | USD 553 k | Vender |
57,195
-170,595
| -75% | -USD 1.04 M | ﹤0.01% | 3521 |
|
|
2023
Q1 | USD 860 k | Comprar |
227,790
+218
| +0.1% | +USD 1.22 k | ﹤0.01% | 3276 |
|
|
2022
Q4 | USD 1.47 M | Vender |
227,572
-188
| -0.1% | -USD 1.55 k | ﹤0.01% | 3135 |
|
|
2022
Q3 | USD 2.02 M | Vender |
227,760
-4,026
| -2% | -USD 40.9 k | ﹤0.01% | 3004 |
|
|
2022
Q2 | USD 2.31 M | Vender |
231,786
-2,256
| -1% | -USD 22.3 k | ﹤0.01% | 2976 |
|
|
2022
Q1 | USD 2.71 M | Vender |
234,042
-10,327
| -4% | -USD 115 k | ﹤0.01% | 2943 |
|
|
2021
Q4 | USD 2.71 M | Vender |
244,369
-25,973
| -10% | -USD 252 k | ﹤0.01% | 3066 |
|
|
2021
Q3 | USD 2.49 M | Vender |
270,342
-1,631
| -0.6% | -USD 17.7 k | ﹤0.01% | 3156 |
|
|
2021
Q2 | USD 3.06 M | Vender |
271,973
-6,783
| -2% | -USD 78.2 k | ﹤0.01% | 3140 |
|
|
2021
Q1 | USD 2.96 M | Vender |
278,756
-25,161
| -8% | -USD 283 k | ﹤0.01% | 3044 |
|
|
2020
Q4 | USD 3.3 M | Vender |
303,917
-13,501
| -4% | -USD 139 k | ﹤0.01% | 2923 |
|
|
2020
Q3 | USD 3.09 M | Vender |
317,418
-22,818
| -7% | -USD 217 k | ﹤0.01% | 2828 |
|
|
2020
Q2 | USD 2.71 M | Vender |
340,236
-411
| -0.1% | -USD 4.24 k | ﹤0.01% | 2865 |
|
|
2020
Q1 | USD 2.96 M | Vender |
340,647
-4,451
| -1% | -USD 46.3 k | ﹤0.01% | 2625 |
|
|
2019
Q4 | USD 3.9 M | Comprar |
345,098
+9,886
| +3% | +USD 105 k | ﹤0.01% | 2733 |
|
|
2019
Q3 | USD 3.64 M | Vender |
335,212
-3,293
| -1% | -USD 35.8 k | ﹤0.01% | 2733 |
|
|
2019
Q2 | USD 3.17 M | Comprar |
338,505
+9,160
| +3% | +USD 92.5 k | ﹤0.01% | 2806 |
|
|
2019
Q1 | USD 4.04 M | Vender |
329,345
-11,209
| -3% | -USD 137 k | ﹤0.01% | 2675 |
|
|
2018
Q4 | USD 4.03 M | Vender |
340,554
-12,731
| -4% | -USD 175 k | ﹤0.01% | 2637 |
|
|
2018
Q3 | USD 5.09 M | Comprar |
353,285
+4,527
| +1% | +USD 62.6 k | ﹤0.01% | 2675 |
|
|
2018
Q2 | USD 5.2 M | Vender |
348,758
-7,090
| -2% | -USD 98.5 k | ﹤0.01% | 2663 |
|
|
2018
Q1 | USD 4.64 M | Comprar |
355,848
+1,380
| +0.4% | +USD 18.1 k | ﹤0.01% | 2634 |
|
|
2017
Q4 | USD 4.47 M | Vender |
354,468
-597
| -0.2% | -USD 7.54 k | ﹤0.01% | 2679 |
|
|
2017
Q3 | USD 4.6 M | Comprar |
355,065
+2,195
| +0.6% | +USD 28.9 k | ﹤0.01% | 2683 |
|
|
2017
Q2 | USD 5.24 M | Comprar |
352,870
+6,189
| +2% | +USD 86.2 k | ﹤0.01% | 2612 |
|
|
2017
Q1 | USD 4.16 M | Comprar |
346,681
+3,165
| +0.9% | +USD 40.1 k | ﹤0.01% | 2670 |
|
|
2016
Q4 | USD 4.74 M | Vender |
343,516
-6,418
| -2% | -USD 88.9 k | ﹤0.01% | 2576 |
|
|
2016
Q3 | USD 4.69 M | Comprar |
349,934
+3,816
| +1% | +USD 46.2 k | ﹤0.01% | 2552 |
|
|
2016
Q2 | USD 3.72 M | Comprar |
346,118
+8,047
| +2% | +USD 88.8 k | ﹤0.01% | 2658 |
|
|
2016
Q1 | USD 3.57 M | Comprar |
338,071
+2,047
| +0.6% | +USD 22.5 k | ﹤0.01% | 2632 |
|
|
2015
Q4 | USD 3.98 M | Comprar |
336,024
+3,635
| +1% | +USD 44.6 k | ﹤0.01% | 2601 |
|
|
2015
Q3 | USD 3.88 M | Comprar |
332,389
+4,729
| +1% | +USD 62.7 k | ﹤0.01% | 2603 |
|
|
2015
Q2 | USD 4.73 M | Vender |
327,660
-3,821
| -1% | -USD 55.1 k | ﹤0.01% | 2556 |
|
|
2015
Q1 | USD 4.62 M | Vender |
331,481
-288
| -0.1% | -USD 3.98 k | ﹤0.01% | 2553 |
|
|
2014
Q4 | USD 4.58 M | Vender |
331,769
-19,815
| -6% | -USD 256 k | ﹤0.01% | 2566 |
|
|
2014
Q3 | USD 4.31 M | Vender |
351,584
-22,694
| -6% | -USD 283 k | ﹤0.01% | 2597 |
|
|
2014
Q2 | USD 4.68 M | Vender |
374,278
-77,413
| -17% | -USD 911 k | ﹤0.01% | 2560 |
|
|
2014
Q1 | USD 5.04 M | Comprar |
451,691
+20,848
| +5% | +USD 229 k | ﹤0.01% | 2546 |
|
|
2013
Q4 | USD 5.22 M | Comprar |
430,843
+21,344
| +5% | +USD 255 k | ﹤0.01% | 2535 |
|
|
2013
Q3 | USD 5 M | Comprar |
409,499
+27,673
| +7% | +USD 386 k | ﹤0.01% | 2507 |
|
|
2013
Q2 | USD 5.04 M | Comprar |
+381,826
| Nuevas | +USD 5.28 M | ﹤0.01% | 2411 |
|
Otros fondos que tienen LFCR en su cartera
Posición de Northern Trust en LFCR: resumen de T2 2026
Northern Trust aumentó su participación en Lifecore Biomedical (LFCR) en 11% durante T2 2026, al comprar aproximadamente USD 129 k y elevar la posición a 253,817 acciones con un valor de USD 1.33 M. La posición representa ﹤0.01% de la cartera y ocupa el puesto #3354.
Northern Trust reportó por primera vez una posición en LFCR en T2 2013 y la ha mantenido durante 53 trimestres desde entonces. La posición alcanzó su máximo de USD 5.24 M en T2 2017. Al cierre de T2 2026, 99 fondos que sigue Wall St. Rank mantienen una posición en LFCR.
- Al cierre de T2 2026, Northern Trust tenía 253,817 acciones de Lifecore Biomedical con un valor de USD 1.33 M.
- Northern Trust compró 25,659 acciones de Lifecore Biomedical en T2 2026, por un monto estimado de USD 129 k.
- Lifecore Biomedical representó ﹤0.01% de la cartera de Northern Trust en T2 2026 y fue su posición número 3354.
- Northern Trust reportó por primera vez una posición en Lifecore Biomedical en T2 2013 y la ha mantenido durante 53 trimestres desde entonces.
- La posición de Northern Trust en Lifecore Biomedical alcanzó su máximo de USD 5.24 M en T2 2017.
- Al cierre de T2 2026, 99 fondos que sigue Wall St. Rank tenían Lifecore Biomedical en cartera.
Según el Informe 13F de Northern Trust correspondiente a T2 2026, presentado el 13 ago 2026.